Results 251 to 260 of about 61,117 (342)

Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects

, 2013
Rajesh Garg, Lindsay Kneen, Gordon H. Williams, Gail K. Adler   +3 more
openalex   +1 more source

Screening and Diagnosis of Primary Aldosteronism in Patients Using Renin‐Angiotensin System Inhibitors

The Journal of Clinical Hypertension, Volume 28, Issue 1, January 2026.
ABSTRACT This study investigated whether patients receiving renin‐angiotensin system inhibitors (RASIs) can undergo reliable screening for primary aldosteronism (PA) without discontinuation of therapy. Consecutive patients with hypertension who underwent PA screening at our hospital between 2016 and 2024 while on RASIs were recruited.
Qian Wang, Hui Dong, Hong‐Wu Li, Yu‐Bao Zou, Xiong‐Jing Jiang   +4 more
wiley   +1 more source

Investigating the efficacy of mineralocorticoid receptor antagonists for cardiovascular outcomes in different diseases. [PDF]

ESC Heart Fail
Wang J, Zheng M, Yang Y, Zhang L, Wulasihan M.   +4 more
europepmc   +1 more source

Loss of Limbic System-Associated Membrane Protein Leads to Reduced Hippocampal Mineralocorticoid Receptor Expression, Impaired Synaptic Plasticity, and Spatial Memory Deficit

, 2010
Shenfeng Qiu, Danielle L. Champagne, Melinda Peters, Elizabeth H. Catania, Edwin J. Weeber, Pat Levitt, Aurea F. Pimenta   +6 more
openalex   +2 more sources

Protective association of renin‐angiotensin system inhibitor use with skeletal muscle wasting in diabetic heart failure

Journal of Diabetes Investigation, Volume 17, Issue 1, Page 73-82, January 2026.
In heart failure, renin‐angiotensin system inhibitor (RASI) use was associated with less skeletal muscle wasting in patients with diabetes, but not in those without diabetes (significant interaction). The association in diabetes was more evident at lower plasma 3‐methylhistidine levels than at higher levels, suggesting a potential biomarker‐defined ...
Hidemichi Kouzu, Toshiyuki Yano, Satoshi Katano, Wataru Kawaharata, Ryo Numazawa, Ryohei Nagaoka, Hiroki Aida, Katsuhiko Ohori, Takefumi Fujito, Nobutaka Nagano, Masato Furuhashi   +10 more
wiley   +1 more source

Density‐Dependent Expression of Epitranscriptomic, Stress and Appetite Regulating Genes in Atlantic Salmon

Molecular Ecology, Volume 35, Issue 1, January 2026.
ABSTRACT Intraspecific competition due to for example, density, has substantial influence on fitness dynamics and life histories, but the underlying physiological mechanisms are often complex and the molecular basis unclear. Further, designing laboratory experiments to measure physiological responses that reflect natural conditions is challenging. Here,
Morgane Frapin, Laura Quispe, Joana Troka, Jenni M. Prokkola, Ossi Laurikainen, Pekka Hyvärinen, Craig R. Primmer, Tutku Aykanat, Ehsan Pashay Ahi   +8 more
wiley   +1 more source

Acid‐sensing ion channel 1a deficiency drives endocrine hypertension in male mice

The Journal of Physiology, Volume 604, Issue 1, Page 172-192, 1 January 2026.
Abstract figure legend Acid‐sensing ion channel 1a deficiency drives endocrine hypertension in aged male mice. Global deletion of ASIC1a (Asic1a−/−) in adult male mice (6 months old) elevates corticosterone, leading to hypokalaemia, volume expansion, increased pulse pressure and cardiomyocyte hypertrophy.
Selina M. Garcia, Megan N. Tuineau, Xavier A. DeLeon, Neil D. Detweiler, Shristey Tamang, Nancy L. Kanagy, Laura V. Gonzalez Bosc, Thomas C. Resta, Jay S. Naik, Nikki L. Jernigan   +9 more
wiley   +1 more source

StAR Protein Deficiency in Clinical Practice: A Case Series From Saudi Arabia

Case Reports in Endocrinology, Volume 2026, Issue 1, 2026.
Objectives Steroidogenic acute regulatory (StAR) protein deficiency is a rare autosomal recessive disorder that disrupts steroid hormone biosynthesis, resulting in congenital adrenal hyperplasia (CAH) and variations in sexual development. However, limited data is available in Saudi Arabia.
Abeer Alabduljabbar, Dania Farooq, Sara Abid, Sara Aljazaeri, Raghad Alhuthil, Afaf Alsagheir, Kalyani Sen   +6 more
wiley   +1 more source

Dose optimization and utilization trends of mineralocorticoid receptor antagonists in heart failure patients with reduced ejection fraction in Ethiopia. [PDF]

Am Heart J Plus
Hassen M, Worku BT, Solomon T, Demessie MB, Wendie TF, Muhammed OS, Gobezie MY.   +6 more
europepmc   +1 more source

The Use of Tranexamic Acid to Treat Melasma: A Systematic Review and Meta‐Analysis

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Introduction Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits bleeding due to its effects on plasminogen conversion, approved by the FDA to treat menorrhagia and prevent bleeding in hemophilia patients undergoing dental extraction.
Nabila Scabine Pessotti, Vinicius Tassoni Civile, Talita Andrade Brandao, Felipe Ribeiro, Gisele Viana de Oliveira, Nathalia Sernizon Guimarães, Denise Steiner, Mahlatse Kgokolo   +7 more
wiley   +1 more source